ONCO · Forms 3, 4, 5
Insider trades at Onconetix, Inc.
No open-market insider buys or sells at Onconetix, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Onconetix, Inc. (ONCO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Onconetix, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% owner | Sell | 49,710 | $0.69 | $34K | Form 4 | |
| HRT FINANCIAL LP | 10% owner | Sell | 94,462 | $0.75 | $71K | Form 4 | |
| HRT FINANCIAL LP | 10% owner | Buy | 34,636 | $0.73 | $25K | Form 4 | |
| HRT FINANCIAL LP | 10% owner | Sell | 53,867 | $0.73 | $39K | Form 4 | |
| HRT FINANCIAL LP | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| HRT FINANCIAL LP | 10% owner | Buy | 92,554 | $0.76 | $70K | Form 4 | |
| HRT FINANCIAL LP | 10% owner | Buy | 74,350 | $0.77 | $57K | Form 4 | |
| David Allan White | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Sammy Dorf | Director | Became an insider (Form 3) | Form 3 | ||||
| Sarah Romano | Director | Became an insider (Form 3) | Form 3 | ||||
| Andrew John Oakley | Director | Other | 20 | Form 4 | |||
| Andrew John Oakley | Director | Award | 618 | Form 4 | |||
| Simon Tarsh | Director | Other | 39 | Form 4 | |||
| Simon Tarsh | Director | Award | 618 | Form 4 | |||
| Thomas Meier | Director | Other | 39 | Form 4 | |||
| Thomas Meier | Director | Award | 618 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.